Workflow
Athira Pharma(ATHA) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical development BOTHELL, Wash., August 7, 2025 – Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today ...
CarGurus(CARG) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 CarGurus Announces Second Quarter 2025 Results & Shares Plans to Wind Down CarOffer Transactions Business Sustained strong momentum in the Marketplace business, with revenue up 14% YoY Q2'25 Net Income of $22.3 million; Non-GAAP Adjusted EBITDA of $77.3 million, up 39% YoY Board approves additional $150 million share repurchase, increasing 2025 authorization to $350 million and extending it through July 2026 1 Second Quarter Financial Highlights Below are our second quarter financial highlights ...
ICU Medical(ICUI) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance SAN CLEMENTE, Calif., August 7, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2025. Second Quarter 2025 Results Second quarter 2025 revenue was $548.9 million, as compared to $596.5 million in the same period in the prior year. GAAP gross ...
AudioEye(AEYE) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 AudioEye Reports Record Second Quarter 2025 Results Thirty-Eighth Consecutive Period of Record Revenue TUCSON, Ariz. — August 7, 2025 — AudioEye, Inc. (Nasdaq: AEYE) ("AudioEye" or the "Company"), the industry-leading digital accessibility company, reported financial results for the second quarter ended June 30, 2025. "We achieved our 38th sequential quarter of growth, a remarkable achievement. We expect annualized sequential revenue growth in the high teens in the second half, driven by busine ...
Atea Pharmaceuticals(AVIR) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update Patient Enrollment Advances in Global Phase 3 Program for Treatment of HCV Four Scientific Posters Presented at EASL, Including Final Results from Phase 2 Study of Bemnifosbuvir/Ruzasvir Regimen Confirming 98% Sustained Virologic Response at 12 Weeks Post-Treatment (SVR12) After Short 8-Week Treatment Duration Regimen of Bemnifosbuvir/Ruzasvir has Potential Best-in-Class Profile with Short Treatment ...
Applied Optoelectronics(AAOI) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Exhibit 99.1 Applied Optoelectronics Reports Second Quarter 2025 Results Sugar Land, Texas, August 7, 2025 – Applied Optoelectronics, Inc. (NASDAQ: AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power the internet, today announced financial results for its second quarter ended June 30, 2025. "We're pleased to deliver revenue and gross margin in line with our expectations," said Dr. Thompson Lin, AOI's Founder, President and Chief Executive Officer. "While EPS came in ...
Alector(ALEC) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
RELEASE $307.3 million in cash, cash equivalents, and investments provides runway into the second half of 2027 Management to host conference call and webcast today at 4:30 p.m. ET/1:30 p.m. PT South San Francisco, Calif., August 7, 2025 -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today reported second quarter 2025 financial results and recent portfolio and business updates. As of ...
Funko(FNKO) - 2025 Q2 - Quarterly Results
2025-08-07 20:11
Funko Reports Second Quarter 2025 Financial Results --Company Provides Comments on H2 Outlook-- EVERETT, Wash. August 7, 2025 -- Funko, Inc. (Nasdaq: FNKO), a leading pop culture lifestyle brand, today reported its consolidated financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Summary: 2025 vs 2024 "As expected, our 2025 second quarter performance was impacted by a dynamic and uncertain tariff environment," said Mike Lunsford, Interim Chief Executive Officer of F ...
Rackspace Technology(RXT) - 2025 Q2 - Quarterly Results
2025-08-07 20:10
Exhibit 99.1 Rackspace Technology Reports Second Quarter 2025 Results SAN ANTONIO, August 7, 2025 – Rackspace Technology, Inc. (Nasdaq: RXT), a leading end-to-end, hybrid cloud and AI solutions company, today announced results for its second quarter ended June 30, 2025. Amar Maletira, Chief Executive Officer, stated, "I am pleased with our second quarter results. Revenue and operating profit exceeded the midpoint of guidance and EPS was within our guided range." Mr. Maletira added, "Go‑to‑market execution a ...
DiamondRock Hospitality pany(DRH) - 2025 Q2 - Quarterly Results
2025-08-07 20:10
COMPANY CONTACTS Briony Quinn Chief Financial Officer (240) 744-1196 Dori Kesten Capital Markets (617) 835-8366 DIAMONDROCK HOSPITALITY COMPANY REPORTS SECOND QUARTER 2025 RESULTS "RevPAR in the second quarter was in line with our expectations, with demand down modestly and rates up compared to the same time last year. Out-of-room spend accelerated from levels experienced in the first quarter, and that trend has continued into the third quarter. Excluding a larger than anticipated property tax increase in C ...